Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute
Sign Up to like & getrecommendations! Published in 2021 at "European Archives of Oto-Rhino-Laryngology"
DOI: 10.1007/s00405-021-06654-3
Abstract: To analyze the outcome of locally advanced unresectable adenoid cystic carcinoma (ACC) of head and neck treated with radical concurrent chemoradiotherapy (CRT) at a single tertiary care centre. Between 2011 and 2018, 23 patients with… read more here.
Keywords: concurrent chemoradiotherapy; locally advanced; head neck; advanced unresectable ... See more keywords
Abstract 4279: GermlineBRCAmutations in Asian patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma (PDAC): Risk categories for genetic testing in Asian population
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-4279
Abstract: Background: Familial PDAC constitutes of 5-10% of all PDAC, and germline mutations in BRCA1 and BRCA2 are associated with increased risk of PDAC. Although previous studies showed the prevalence of BRCA1 and BRCA2 germline mutations… read more here.
Keywords: unresectable metastatic; germline; pdac; advanced unresectable ... See more keywords
Abstract CT177: INO-5401 + INO-9012 in combination with atezolizumab for locally advanced unresectable or metastatic/recurrent urothelial carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs18-ct177
Abstract: Background: Advanced urothelial carcinoma (UCa; bladder cancer) remains a deadly disease with patients often failing to respond to, or ineligible for, platinum-based therapy. Checkpoint inhibitors (CPIs) have increased response rates, but a majority of patients… read more here.
Keywords: ino 9012; locally advanced; 5401 ino; advanced unresectable ... See more keywords
Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.4086
Abstract: 4086Background: Recently, checkpoint inhibitors have shown modest activity in patients (pts) with advanced, unresectable hepatocellular carcinoma (HCC). In multicenter trials with nivolumab and pem... read more here.
Keywords: hepatocellular carcinoma; unresectable hepatocellular; advanced unresectable; study pembrolizumab ... See more keywords
Efficacy and safety of mFOLFIRINOX in patients with borderline resectable and locally advanced unresectable pancreatic cancer: Intention-to-treat population analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.4_suppl.720
Abstract: 720Background: Borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAUPC) are heterogeneous disease entity with various prognosis. Based on the phase... read more here.
Keywords: unresectable pancreatic; pancreatic cancer; advanced unresectable; borderline resectable ... See more keywords
The metformin has no significant anticancer effect on patients with advanced or unresectable cancer: systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Current pharmaceutical design"
DOI: 10.2174/1381612828666220329113434
Abstract: BACKGROUND At present, the antitumor effect of metformin is controversial. Previous meta-analyses included observational studies, of which the results can be influenced by many confounders, affecting the result of meta-analyses and weakening the strength of… read more here.
Keywords: meta analysis; effect; patients advanced; advanced unresectable ... See more keywords